, South Korea

South Korean motor insurers turns profit for the first time in four years

The pandemic played a huge role in this for motor insurers.

South Korean motor insurers were able to turn to profit for the first time in four years in 2021 thanks mostly to fall in loss rate, and rise in premiums and subscribers due to the pandemic, according to data by the Financial Supervisory Commission (FSC).

The 12 car insurers’ combined operating income totaled $320m in 2021, a turnaround from a loss of $310m from a year earlier.

By end-2021, the car insurance industry grew to ₩20.28t ($16b) in terms of original premiums, an increase of 3.7% from a year before. This also marks the first time that the market size exceeded the 20-trillion-won mark.

The FSS said the turnaround was caused by a rise in insurance premiums and subscribers as well as lower loss rates because of limited outdoor activity during the pandemic.

They turned to a profit for the first time since 2017.

The FSS said it will monitor the car insurance market with the expectancy of accident rates increasing as social distancing rules are lifted. 

You may also like: 

Kakao gets regulator nod for digital insurance business

Ping An eyes $39.28b in green insurance premiums by 2025

Tokio Marine’s GCube expands footprint in Australia

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.